Investigation finds Biogen set 'unjustifiably high price' for Aduhelm; Eric Lander's next act
In the Aduhelm Files, STAT explains the significance of a congressional investigation of the FDA, Biogen, and an Alzheimer...Read More
The Aduhelm Files: FDA, Biogen, and a drug development debacle
From STAT's first investigations in June 2021, we have relentlessly stayed on the story. ...Read More
The Aduhelm Files: a STAT three-part package
'Rife with irregularities': What an 18-month congressional investigation reveals about the FDA's approval of...Read More
Paid sick leave can help the tripledemic
The latest stories trending on MedCity News. ...Read More
Subscribe to:
Posts
(
Atom
)